5 completed. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 2 | 3 | Completed 3 |
Follow Interstitial Cystitis: new trials by email Literature Review of Interstitial Cystitis trials Research Report on Interstitial Cystitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PK and Safety of SI-722 in IC/BPS SI-722, Placebo - Interstitial Cystitis, Bladder Pain Syndrome | Phase 1 / Phase 2 | Completed | Seikagaku Corporation | 33 | 2020-03-30 | 2023-12-29 |
| Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients TC-3 Gel mixed with Botox (BTX) - Interstitial Cystitis, IC | Phase 1 / Phase 2 | Completed | UroGen Pharma Ltd. | 15 | 2013-11-01 | 2016-04-12 |
| Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome TTI-1612 - Interstitial Cystitis | Phase 1 | Completed | Trillium Therapeutics Inc. | 28 | 2012-03-01 | 2013-06-26 |
| Safety Study of LiRIS in Interstitial Cystitis (IC) Patients LiRIS low dose and LiRIS high dose - Interstitial Cystitis | Phase 1 | Completed | Allergan | 18 | 2010-07-01 | 2014-11-25 |
| Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis capsaicin, Placebo - Interstitial Cystitis, Vulvar Diseases | Phase 1 / Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 139 | 1995-06-01 | 2025-05-04 |
Cystitis, Interstitial (5) · Cystitis (1) · Nocturia (1) · Pain (1) · Rare Diseases (1) · Urogenital Diseases (1) · Vulvar Diseases (1) · Vulvar Vestibulitis (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Male Urogenital Diseases (5) · Urinary Bladder Diseases (5) · Urologic Diseases (5) · Cystitis (4) · Urogenital Diseases (4) · Pathological Conditions, Signs and Symptoms (2) · Disease Attributes (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Lower Urinary Tract Symptoms (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Signs and Symptoms (1)
Capsaicin (1)
Allergan (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Seikagaku Corporation (1) · Trillium Therapeutics Inc. (1) · UroGen Pharma Ltd. (1)
Canada (2) · United States (2) · Israel (1)
Amnon Zisman, MD (1) · Curtis Nickel, MD (1) · Hugh Flood (1) · Penka Petrova, PhD (1)
R01DK049524 (1)